330 related articles for article (PubMed ID: 26972815)
21. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system.
Hsu CY; Lee YH; Hsia CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Lee FY; Huo TI
Hepatology; 2013 Jan; 57(1):112-9. PubMed ID: 22806819
[TBL] [Abstract][Full Text] [Related]
22. A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.
An C; Wu S; Huang Z; Ni J; Zuo M; Gu Y; Zhang T; Huang J
Cancer Med; 2020 Jan; 9(1):104-115. PubMed ID: 31714685
[TBL] [Abstract][Full Text] [Related]
23. Survival benefit of hepatic resection for hepatocellular carcinoma beyond the Barcelona Clinic Liver Cancer classification.
Furukawa K; Shiba H; Horiuchi T; Shirai Y; Haruki K; Fujiwara Y; Sakamoto T; Gocho T; Yanaga K
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):199-205. PubMed ID: 28160422
[TBL] [Abstract][Full Text] [Related]
24. Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma.
Yau T; Tang VY; Yao TJ; Fan ST; Lo CM; Poon RT
Gastroenterology; 2014 Jun; 146(7):1691-700.e3. PubMed ID: 24583061
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.
Huang J; Liu FC; Li L; Yuan SX; Yang Y; Jiang BG; Liu H; Pan ZY
Am J Clin Oncol; 2020 Jan; 43(1):20-27. PubMed ID: 31633514
[TBL] [Abstract][Full Text] [Related]
26. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a Nomogram by Integrating Molecular Markers and Tumor-Node-Metastasis Staging System for Predicting the Prognosis of Hepatocellular Carcinoma.
Huang XT; Chen LH; Huang CS; Li JH; Cai JP; Chen W; Yin XY
Dig Surg; 2019; 36(5):426-432. PubMed ID: 30481744
[TBL] [Abstract][Full Text] [Related]
28. Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients.
Liu PH; Hsu CY; Hsia CY; Lee YH; Huang YH; Su CW; Lee FY; Lin HC; Huo TI
Eur J Cancer; 2016 Aug; 63():25-33. PubMed ID: 27259100
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
[TBL] [Abstract][Full Text] [Related]
30. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation.
Sangro B; Carpanese L; Cianni R; Golfieri R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Van Buskirk M; Bilbao JI; Ettorre GM; Salvatori R; Giampalma E; Geatti O; Wilhelm K; Hoffmann RT; Izzo F; Iñarrairaegui M; Maini CL; Urigo C; Cappelli A; Vit A; Ahmadzadehfar H; Jakobs TF; Lastoria S;
Hepatology; 2011 Sep; 54(3):868-78. PubMed ID: 21618574
[TBL] [Abstract][Full Text] [Related]
31. A Proposal for Modification of the Barcelona Clinic Liver Cancer Staging System Considering the Prognostic Implication of Performance Status.
Cho HJ; Kim SS; Kang SY; Yang MJ; Noh CK; Hwang JC; Lim SG; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim JH; Cho SW; Cheong JY;
Gut Liver; 2019 Sep; 13(5):557-568. PubMed ID: 31023007
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy.
Huo RR; Liu X; Cui J; Ma L; Huang KH; He CY; Yang Y; You XM; Yuan WP; Xiang BD; Zhong JH; Li LQ
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32478394
[TBL] [Abstract][Full Text] [Related]
33. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
[TBL] [Abstract][Full Text] [Related]
34. A model prediction of long-term prognosis in patients with centrally located hepatocellular carcinoma undergoing hepatectomy.
Yantong Y; Shan L; Zhijie C; Youwei Z
Eur J Surg Oncol; 2018 Oct; 44(10):1595-1602. PubMed ID: 30041973
[TBL] [Abstract][Full Text] [Related]
35. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM; Sinn DH; Jung SH; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2016 Oct; 36(10):1490-7. PubMed ID: 26936471
[TBL] [Abstract][Full Text] [Related]
36. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization.
Xu L; Peng ZW; Chen MS; Shi M; Zhang YJ; Guo RP; Lin XJ; Lau WY
J Hepatol; 2015 Jul; 63(1):122-30. PubMed ID: 25725438
[TBL] [Abstract][Full Text] [Related]
37. Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.
Kitai S; Kudo M; Izumi N; Kaneko S; Ku Y; Kokudo N; Sakamoto M; Takayama T; Nakashima O; Kadoya M; Matsuyama Y; Matsunaga T
Dig Dis; 2014; 32(6):717-24. PubMed ID: 25376289
[TBL] [Abstract][Full Text] [Related]
38. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection.
Huang JL; Fu YP; Jing CY; Yi Y; Sun J; Gan W; Lu ZF; Zhou J; Fan J; Qiu SJ
J Surg Oncol; 2018 Mar; 117(4):625-633. PubMed ID: 29165812
[TBL] [Abstract][Full Text] [Related]
39. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
[TBL] [Abstract][Full Text] [Related]
40. Survival Predictability Between the American Joint Committee on Cancer 8th Edition Staging System and the Barcelona Clinic Liver Cancer Classification in Patients with Hepatocellular Carcinoma.
Chen LJ; Chang YJ; Chang YJ
Oncologist; 2021 Mar; 26(3):e445-e453. PubMed ID: 32969134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]